BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2164667)

  • 1. Effects of kappa- and mu-selective opiate agonists on colonic temperature in normoglycaemic and streptozotocin-treated hyperglycaemic mice.
    Bansinath M; Ramabadran K; Turndorf H; Puig MM
    Pharmacol Toxicol; 1990 May; 66(5):324-8. PubMed ID: 2164667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperglycaemia as a factor affecting kappa-opiate agonist-induced inhibition of the gastrointestinal transit in mice.
    Ramabadran K; Bansinath M; Turndorf H; Puig MM
    J Pharm Pharmacol; 1989 Jul; 41(7):496-8. PubMed ID: 2570861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperglycemia does not modify the pupillary effects of mu and kappa opiate agonists in mice.
    Bansinath M; Ramabadran K; Turndorf H; Puig MM
    J Ocul Pharmacol; 1989; 5(1):33-43. PubMed ID: 2541211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pertussis and cholera toxins modulate kappa-opioid receptor agonists-induced hypothermia and gut inhibition.
    Shukla VK; Turndorf H; Bansinath M
    Eur J Pharmacol; 1995 Mar; 292(3-4):293-9. PubMed ID: 7796869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tonic pain perception in the mouse: differential modulation by three receptor-selective opioid agonists.
    Murray CW; Cowan A
    J Pharmacol Exp Ther; 1991 Apr; 257(1):335-41. PubMed ID: 1850470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between the discriminative stimulus effects of mu and kappa opioid agonists in the squirrel monkey.
    Negus SS; Picker MJ; Dykstra LA
    J Pharmacol Exp Ther; 1991 Jan; 256(1):149-58. PubMed ID: 1846412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereospecific inhibition of gastrointestinal transit by kappa opioid agonists in mice.
    Ramabadran K; Bansinath M; Turndorf H; Puig MM
    Eur J Pharmacol; 1988 Oct; 155(3):329-31. PubMed ID: 2853069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
    Picker MJ; Dykstra LA
    J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
    Baker AK; Meert TF
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-tolerance between mu- and kappa-opioid agonists in the guinea pig ileum myenteric plexus.
    Garaulet JV; Laorden ML; Milanés MV
    J Pharmacol Exp Ther; 1994 Jun; 269(3):993-9. PubMed ID: 8014886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of mu- and kappa-opioid agonists on the electroconvulsive seizure threshold in mice and antagonism by naloxone and MR 2266.
    Frey HH
    Pharmacol Toxicol; 1988 Mar; 62(3):150-4. PubMed ID: 2836842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential cross-tolerance to mu and kappa opioid agonists in morphine-tolerant rats responding under a schedule of food presentation.
    Picker MJ; Negus SS; Powell KR
    Psychopharmacology (Berl); 1991; 103(1):129-35. PubMed ID: 1848712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
    Capasso A; Sorrentino L
    Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulatory activity of mu- and kappa-selective opioid agonists.
    Taub DD; Eisenstein TK; Geller EB; Adler MW; Rogers TJ
    Proc Natl Acad Sci U S A; 1991 Jan; 88(2):360-4. PubMed ID: 1846441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of mu and kappa opioid receptor agonists on rat plasma corticosterone levels.
    Hayes AG; Stewart BR
    Eur J Pharmacol; 1985 Oct; 116(1-2):75-9. PubMed ID: 2996912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kappa-opiate agonist-induced inhibition of gastrointestinal transit in different strains of mice.
    Bansinath M; Ramabadran K; Turndorf H; Puig MM
    Pharmacology; 1991; 42(2):97-102. PubMed ID: 1648236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracerebroventricular administration of kappa-agonists induces convulsions in mice.
    Bansinath M; Ramabadran K; Turndorf H; Shukla VK
    Brain Res Bull; 1991 Jul; 27(1):75-9. PubMed ID: 1657321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid receptor agonists in the rabbit colon: comparison of in vivo and in vitro studies.
    Pairet M; Ruckebusch Y
    Life Sci; 1984 Oct; 35(16):1653-8. PubMed ID: 6148681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of central mu, delta-1, and kappa-1 opioid receptors in opioid-induced muscle rigidity in the rat.
    Vankova ME; Weinger MB; Chen DY; Bronson JB; Motis V; Koob GF
    Anesthesiology; 1996 Sep; 85(3):574-83. PubMed ID: 8853088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mu- and kappa-opiate agonists modulate ingestive behaviors in the slug, Limax maximus.
    Kavaliers M; Rangeley RW; Hirst M; Teskey GC
    Pharmacol Biochem Behav; 1986 Mar; 24(3):561-6. PubMed ID: 3010335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.